Last updated at 21 May 2025 11:06 AM
Director
DIN: 10489886
Mallikarjuna Reddy Pudaka is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at VENSURA PHARMA INSTITUTE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10489886.Mallikarjuna Reddy Pudaka is currently involved in 2 different roles. Their most recent position is with TIRUPATI RESEARCH & DEVELOPMENT PRIVATE LIMITED as a Additional Director. The first company Mallikarjuna Reddy Pudaka was appointed to as a director was VENSURA PHARMA INSTITUTE PRIVATE LIMITED. Mallikarjuna Reddy Pudaka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mallikarjuna Reddy Pudaka is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at VENSURA PHARMA INSTITUTE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10489886.Mallikarjuna Reddy Pudaka is currently involved in 2 different roles. Their most recent position is with TIRUPATI RESEARCH & DEVELOPMENT PRIVATE LIMITED as a Additional Director. The first company Mallikarjuna Reddy Pudaka was appointed to as a director was VENSURA PHARMA INSTITUTE PRIVATE LIMITED. Mallikarjuna Reddy Pudaka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
5 Months 3 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| VENSURA PHARMA INSTITUTE PRIVATE LIMITED | Director | 02-Feb-2024 |
| TIRUPATI RESEARCH & DEVELOPMENT PRIVATE LIMITED | Additional Director | 15-Feb-2025 |